Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations

Conditions

• Non Small Cell Lung Cancer

Interventions

• DRUG: Metformin Hydrochloride
• OTHER: Placebo

Sponsor

Instituto Nacional de Cancerologia de Mexico